Invention Grant
- Patent Title: Crystalline form of ANAVEX2-73 for the treatment of Alzheimer's disease
-
Application No.: US15622588Application Date: 2017-06-14
-
Publication No.: US10426754B2Publication Date: 2019-10-01
- Inventor: Marco Cecchi
- Applicant: Anavex Life Sciences Corp.
- Applicant Address: US NY New York
- Assignee: ANAVEX LIFE SCIENCES CORP.
- Current Assignee: ANAVEX LIFE SCIENCES CORP.
- Current Assignee Address: US NY New York
- Agency: Polsinelli PC
- Agent Tara A. Nealey
- Main IPC: A61K31/341
- IPC: A61K31/341 ; A61K45/06 ; A61K31/13 ; A61K31/27 ; A61K31/445 ; A61K31/55 ; A61K9/00
Abstract:
Composition and method for treatment of Alzheimer's disease that includes ANAVEX2-73. Method of treatment of Alzheimer's disease using pharmaceutical compositions comprising ANAVEX2-73 according to an intermittent dosage regimen.
Public/Granted literature
- US20180360796A1 Anavex2-73 for the Treatment of Alzheimer's Disease Public/Granted day:2018-12-20
Information query
